top of page


The Future of Biosimilars
In the United States, Biologics account for 40% of all pharmaceutical spending, however fewer than 2% of Americans use them. What makes...

Subash Rajavel
3 min read


DCT and the deluge of data
The new fashionable kid in the world of clinical trials is obviously DCT aka the Decentralized Clinical Trials. Like other dormant trends...

Subash Rajavel
4 min read


The future of patient engagement
I called one of my specialist Doctor’s offices to send over my clinical data to my primary physician. After multiple failed attempts to...

Subash Rajavel
4 min read
bottom of page